HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosa Gallego Selected Research

Insulin-Like Growth Factor Binding Protein 3

1/2011Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD study.
8/2009Prognostic role of plasma insulin-like growth factor (IGF) and IGF-binding protein 3 in metastatic colorectal cancer.
3/2009Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosa Gallego Research Topics

Disease

11Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 07/2005
3Neoplasms (Cancer)
11/2014 - 09/2007
2Rectal Neoplasms (Rectal Cancer)
11/2014 - 06/2009
2Neoplasm Metastasis (Metastasis)
05/2011 - 05/2009
2Melanoma (Melanoma, Malignant)
10/2007 - 04/2006
1Adenocarcinoma
11/2014
1Microsatellite Instability
07/2014
1Type 2 Diabetes Mellitus (MODY)
03/2011
1Disease Progression
03/2009
1Febrile Neutropenia
11/2008
1Diarrhea
11/2008
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2006
1Brain Neoplasms (Brain Tumor)
04/2006
1Esophageal Neoplasms (Esophageal Cancer)
05/2005
1Carcinoma (Carcinomatosis)
05/2005

Drug/Important Bio-Agent (IBA)

4Irinotecan (Camptosar)FDA LinkGeneric
03/2013 - 11/2008
4Matrix Metalloproteinase 7 (Matrilysin)IBA
04/2011 - 09/2007
3Cetuximab (Erbitux)FDA Link
03/2013 - 01/2011
3Insulin-Like Growth Factor Binding Protein 3IBA
01/2011 - 03/2009
2Fluorouracil (Carac)FDA LinkGeneric
11/2014 - 05/2005
2ErbB Receptors (EGF Receptor)IBA
04/2011 - 12/2006
2Insulin-Like Growth Factor I (IGF-1)IBA
01/2011 - 03/2009
2Cisplatin (Platino)FDA LinkGeneric
11/2008 - 05/2005
2Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2005 - 05/2005
1XELOXIBA
07/2014
1Metformin (Glucophage)FDA LinkGeneric
03/2011
1Panitumumab (Vectibix)FDA Link
01/2011
1Insulin-Like PeptidesIBA
08/2009
1Capecitabine (Xeloda)FDA Link
06/2009
1Peptide Hydrolases (Proteases)FDA Link
03/2009
1EnzymesIBA
03/2009
1Docetaxel (Taxotere)FDA Link
11/2008
1InterferonsIBA
10/2007
1Metalloproteases (Metalloproteinases)IBA
09/2007
1GemcitabineFDA Link
12/2006
1Gefitinib (Iressa)FDA Link
12/2006
1Temozolomide (Temodar)FDA LinkGeneric
04/2006
1Fas Ligand Protein (Fas Ligand)IBA
07/2005

Therapy/Procedure

7Therapeutics
11/2014 - 07/2005
6Drug Therapy (Chemotherapy)
12/2020 - 04/2006
4Radiotherapy
11/2014 - 05/2005
1Chemoradiotherapy
11/2014
1Neoadjuvant Therapy
06/2009
1Aftercare (After-Treatment)
07/2005